Skip to main content

Table 2 Results summary

From: Antihistamine effects and safety of fexofenadine: a systematic review and Meta-analysis of randomized controlled trials

Outcome measuresFEX vs. 1st gen AHFEX vs. 2nd gen AHFEX vs. PL
Included studiesnumberHeterogeneity (%)PIncluded studiesnumberHeterogeneity (%)PIncluded studiesnumberHeterogeneity (%)P
Antihistamine effectsInhibition rate of wheal    5130990.21051048<0.001
Inhibition rate of flare    41001000.840517696< 0.001
Safety profilesAE1052200.03122569900.89037859100.987
SE1052200.04627647100.00238870000.120
CFF623298<0.0013118890.2806232850.170
CRT725497<0.0014140760.2206206890.280
CTT392980.04039248<0.001392950.960
LARS7272990.0033118960.002727290<0.001
VAS of drowsiness21020<0.001    3116970.070